Clinical Trials

Alliance A021502

Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: AdjuvantTrial of Deficient Mismatch Repair in Colon Cancer)

Objective

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair.

NCT# 02912559

Clinical Trial Categories

  • Gastrointestinal & Gastroesophageal Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at (603) 224-2556

Location

  • Payson Center for Cancer Care
    Concord Hospital
    250 Pleasant Street
    Concord, NH 03301
    Main: (603) 230-6000